Rare FLT3 deletion mutants may provide additional treatment options to patients with AML: an approach to individualized medicine

Leukemia. 2015 Dec;29(12):2434-8. doi: 10.1038/leu.2015.131. Epub 2015 May 27.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Gene Deletion
  • HEK293 Cells
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / genetics
  • Mutation*
  • Precision Medicine*
  • fms-Like Tyrosine Kinase 3 / chemistry
  • fms-Like Tyrosine Kinase 3 / genetics*

Substances

  • FLT3 protein, human
  • fms-Like Tyrosine Kinase 3